Viewing Study NCT07102368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-12 @ 10:59 PM
Study NCT ID: NCT07102368
Status: RECRUITING
Last Update Posted: 2025-10-10
First Post: 2025-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Sponsor: Janssen-Cilag G.m.b.H
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inflammatory Bowel Disease View
None Colitis, Ulcerative View
None Crohn's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IBD View
None Ulcerative Colitis View
None Crohn's Disease View
None Gastroenteritis View
None Gastrointestinal Diseases View
None Digestive System Diseases View
None Colonic Diseases View
None Intestinal Diseases View
None Pathologic Processes View
None Inflammatory Bowel Diseases View
None Colitis, Ulcerative View
None Ulcer View
None Guselkumab View
None Tremfya View
None Inflammatory View